Most patients experience mild side effects, like nausea, diarrhea, constipation, or abdominal pain
The battle between GLP-1 receptor agonists (semaglutide) and dual GLP-1/GIP agonists (tirzepatide) is reshaping both diabetes & obesity treatment
Klinic prescribes four FDA-approved, branded weight loss medications: Wegovy (a once-weekly semaglutide injection), Oral Wegovy (a daily semaglutide pill), Zepbound (a once-weekly tirzepatide injection that targets both GLP-1 and GIP), and Foundayo (a once-daily orforglipron pill that can be taken at any time with no food or water restrictions)
If you are seeking guidance as to whether our Newport Beach Medical Weight Loss Programs are right for you, schedule a consultation today by calling 949.867.0091 Benefits of the Semaglutide and Tirzepatide Weight Loss Program Choosing our weight loss program with Semaglutide (GLP-1) Ozempic and Tirzepatide (GLP-1/GIP) Mounjaro offers several advantages: Clinically Proven Results: Semaglutide and Tirzepatide have been shown to significantly reduce body weight in clinical studies
The decision tree matters
